Atıcı, Y. 2022. Evaluation of serum growth arrest specific-6/sAXL levels in type 2 diabetes mellitus. Erciyes Med J , vol.1, no.1 , 1-14.

Atıcı, Y., (2022). Evaluation of serum growth arrest specific-6/sAXL levels in type 2 diabetes mellitus. Erciyes Med J , vol.1, no.1, 1-14.

Atıcı, YASEMİN. "Evaluation of serum growth arrest specific-6/sAXL levels in type 2 diabetes mellitus," Erciyes Med J , vol.1, no.1, 1-14, 2022

Atıcı, YASEMİN. "Evaluation of serum growth arrest specific-6/sAXL levels in type 2 diabetes mellitus." Erciyes Med J , vol.1, no.1, pp.1-14, 2022

Atıcı, Y. (2022) . "Evaluation of serum growth arrest specific-6/sAXL levels in type 2 diabetes mellitus." Erciyes Med J , vol.1, no.1, pp.1-14.

@article{article, author={YASEMİN ATICI}, title={Evaluation of serum growth arrest specific-6/sAXL levels in type 2 diabetes mellitus}, journal={Erciyes Med J}, year=2022, pages={1-14} }